Global Intravenous Immunoglobulin(IVIg) Therapy Supply, Demand and Key Producers, 2026-2032
The global Intravenous Immunoglobulin(IVIg) Therapy market size is expected to reach $ 33466 million by 2032, rising at a market growth of 7.4% CAGR during the forecast period (2026-2032).
Intravenous Immunoglobulin (IVIg) Therapy refers to the intravenous administration of highly purified polyclonal IgG antibodies derived from pooled human plasma, aimed at supplementing or modulating a patient?s immune function. It is widely used in the treatment of primary immunodeficiency diseases, autoimmune disorders, neurological conditions, and certain inflammatory diseases. IVIg exerts its effects through multiple mechanisms, including pathogen neutralization, inhibition of autoantibodies, modulation of Fc receptor expression, and regulation of cytokine networks. As a foundational therapy in clinical immunology, IVIg therapy holds a significant position in critical care and chronic disease management due to its established safety profile and broad therapeutic coverage.In 2025, global Intravenous Immunoglobulin (IVIg) Therapy production reached approximately 164.59 million units and price is about 120 USD/Unit.The average gross profit margin of this product is 60%.
The rising prevalence of immune-related diseases and improvements in diagnostic capabilities provide sustained growth momentum for IVIg therapy. Expansion into neurological and rare disease indications continues to broaden clinical applications. Accelerating population aging increases the number of patients with immune dysfunction-related conditions. Enhanced reimbursement coverage for major diseases improves patient accessibility. Technological advancements in purification processes and the introduction of high-concentration formulations enhance treatment efficiency and clinical acceptance, supporting steady market development.
IVIg therapy relies heavily on human plasma resources, which are inherently limited and sensitive to regulatory policies and public health events. The manufacturing process is complex, requiring stringent viral inactivation and purification standards, resulting in high production costs. In certain regions, price controls or centralized procurement policies may constrain profitability. Emerging biologics and targeted therapies are gaining traction in specific indications, creating competitive pressure. Strengthened rational-use regulations may also limit inappropriate utilization.
Downstream demand is concentrated in tertiary hospitals, neurology centers, immunology clinics, and rare disease treatment institutions. Treatment patterns are evolving from acute rescue use toward long-term maintenance and personalized management. High-concentration formulations and more convenient administration approaches are gaining attention, although intravenous infusion remains dominant in critical care settings. The adoption of multidisciplinary care models improves indication recognition and standardized usage. Enhanced patient education contributes to improved long-term treatment adherence.
The core raw material for IVIg therapy is plasma collected from healthy donors, with quality directly influencing product safety and stability. Plasma collection depends on compliant donation systems and strict screening procedures. Manufacturing involves separation reagents, chromatography resins, viral inactivation solvents, and sterile filling consumables. Cold chain logistics and batch release management ensure end-to-end quality control. As global competition for plasma resources intensifies, upstream supply security has become a key competitive barrier in the industry.
This report studies the global Intravenous Immunoglobulin(IVIg) Therapy production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Intravenous Immunoglobulin(IVIg) Therapy and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Intravenous Immunoglobulin(IVIg) Therapy that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Intravenous Immunoglobulin(IVIg) Therapy total production and demand, 2021-2032, (K Units)
Global Intravenous Immunoglobulin(IVIg) Therapy total production value, 2021-2032, (USD Million)
Global Intravenous Immunoglobulin(IVIg) Therapy production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Units), (based on production site)
Global Intravenous Immunoglobulin(IVIg) Therapy consumption by region & country, CAGR, 2021-2032 & (K Units)
U.S. VS China: Intravenous Immunoglobulin(IVIg) Therapy domestic production, consumption, key domestic manufacturers and share
Global Intravenous Immunoglobulin(IVIg) Therapy production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Units)
Global Intravenous Immunoglobulin(IVIg) Therapy production by Type, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
Global Intravenous Immunoglobulin(IVIg) Therapy production by Application, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
This report profiles key players in the global Intravenous Immunoglobulin(IVIg) Therapy market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Takeda, CSL, Grifols, Octapharma, Kedrion, LFB Group, Biotest, BPL, RAAS, CBPO, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Intravenous Immunoglobulin(IVIg) Therapy market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Intravenous Immunoglobulin(IVIg) Therapy Market, By Region:
1. How big is the global Intravenous Immunoglobulin(IVIg) Therapy market?
2. What is the demand of the global Intravenous Immunoglobulin(IVIg) Therapy market?
3. What is the year over year growth of the global Intravenous Immunoglobulin(IVIg) Therapy market?
4. What is the production and production value of the global Intravenous Immunoglobulin(IVIg) Therapy market?
5. Who are the key producers in the global Intravenous Immunoglobulin(IVIg) Therapy market?
6. What are the growth factors driving the market demand?
Intravenous Immunoglobulin (IVIg) Therapy refers to the intravenous administration of highly purified polyclonal IgG antibodies derived from pooled human plasma, aimed at supplementing or modulating a patient?s immune function. It is widely used in the treatment of primary immunodeficiency diseases, autoimmune disorders, neurological conditions, and certain inflammatory diseases. IVIg exerts its effects through multiple mechanisms, including pathogen neutralization, inhibition of autoantibodies, modulation of Fc receptor expression, and regulation of cytokine networks. As a foundational therapy in clinical immunology, IVIg therapy holds a significant position in critical care and chronic disease management due to its established safety profile and broad therapeutic coverage.In 2025, global Intravenous Immunoglobulin (IVIg) Therapy production reached approximately 164.59 million units and price is about 120 USD/Unit.The average gross profit margin of this product is 60%.
The rising prevalence of immune-related diseases and improvements in diagnostic capabilities provide sustained growth momentum for IVIg therapy. Expansion into neurological and rare disease indications continues to broaden clinical applications. Accelerating population aging increases the number of patients with immune dysfunction-related conditions. Enhanced reimbursement coverage for major diseases improves patient accessibility. Technological advancements in purification processes and the introduction of high-concentration formulations enhance treatment efficiency and clinical acceptance, supporting steady market development.
IVIg therapy relies heavily on human plasma resources, which are inherently limited and sensitive to regulatory policies and public health events. The manufacturing process is complex, requiring stringent viral inactivation and purification standards, resulting in high production costs. In certain regions, price controls or centralized procurement policies may constrain profitability. Emerging biologics and targeted therapies are gaining traction in specific indications, creating competitive pressure. Strengthened rational-use regulations may also limit inappropriate utilization.
Downstream demand is concentrated in tertiary hospitals, neurology centers, immunology clinics, and rare disease treatment institutions. Treatment patterns are evolving from acute rescue use toward long-term maintenance and personalized management. High-concentration formulations and more convenient administration approaches are gaining attention, although intravenous infusion remains dominant in critical care settings. The adoption of multidisciplinary care models improves indication recognition and standardized usage. Enhanced patient education contributes to improved long-term treatment adherence.
The core raw material for IVIg therapy is plasma collected from healthy donors, with quality directly influencing product safety and stability. Plasma collection depends on compliant donation systems and strict screening procedures. Manufacturing involves separation reagents, chromatography resins, viral inactivation solvents, and sterile filling consumables. Cold chain logistics and batch release management ensure end-to-end quality control. As global competition for plasma resources intensifies, upstream supply security has become a key competitive barrier in the industry.
This report studies the global Intravenous Immunoglobulin(IVIg) Therapy production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Intravenous Immunoglobulin(IVIg) Therapy and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Intravenous Immunoglobulin(IVIg) Therapy that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Intravenous Immunoglobulin(IVIg) Therapy total production and demand, 2021-2032, (K Units)
Global Intravenous Immunoglobulin(IVIg) Therapy total production value, 2021-2032, (USD Million)
Global Intravenous Immunoglobulin(IVIg) Therapy production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Units), (based on production site)
Global Intravenous Immunoglobulin(IVIg) Therapy consumption by region & country, CAGR, 2021-2032 & (K Units)
U.S. VS China: Intravenous Immunoglobulin(IVIg) Therapy domestic production, consumption, key domestic manufacturers and share
Global Intravenous Immunoglobulin(IVIg) Therapy production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Units)
Global Intravenous Immunoglobulin(IVIg) Therapy production by Type, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
Global Intravenous Immunoglobulin(IVIg) Therapy production by Application, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
This report profiles key players in the global Intravenous Immunoglobulin(IVIg) Therapy market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Takeda, CSL, Grifols, Octapharma, Kedrion, LFB Group, Biotest, BPL, RAAS, CBPO, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Intravenous Immunoglobulin(IVIg) Therapy market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Intravenous Immunoglobulin(IVIg) Therapy Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Liquid
- Powder
- Low Concentration
- Medium Concentration
- High Concentration
- Acute Therapy
- Maintenance Therapy
- Critical Care
- Immunodeficiency
- Autoimmune Disease
- Acute Infection
- Others
- Takeda
- CSL
- Grifols
- Octapharma
- Kedrion
- LFB Group
- Biotest
- BPL
- RAAS
- CBPO
- Hualan Bio
- Tiantan Bio
- Shuanglin Bio
- Boya Bio
- Yuanda Shuyang
- Weiguang Bio
- Nanyue Bio
- KM Biologics
1. How big is the global Intravenous Immunoglobulin(IVIg) Therapy market?
2. What is the demand of the global Intravenous Immunoglobulin(IVIg) Therapy market?
3. What is the year over year growth of the global Intravenous Immunoglobulin(IVIg) Therapy market?
4. What is the production and production value of the global Intravenous Immunoglobulin(IVIg) Therapy market?
5. Who are the key producers in the global Intravenous Immunoglobulin(IVIg) Therapy market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Intravenous Immunoglobulin(IVIg) Therapy Introduction
1.2 World Intravenous Immunoglobulin(IVIg) Therapy Supply & Forecast
1.2.1 World Intravenous Immunoglobulin(IVIg) Therapy Production Value (2021 & 2025 & 2032)
1.2.2 World Intravenous Immunoglobulin(IVIg) Therapy Production (2021-2032)
1.2.3 World Intravenous Immunoglobulin(IVIg) Therapy Pricing Trends (2021-2032)
1.3 World Intravenous Immunoglobulin(IVIg) Therapy Production by Region (Based on Production Site)
1.3.1 World Intravenous Immunoglobulin(IVIg) Therapy Production Value by Region (2021-2032)
1.3.2 World Intravenous Immunoglobulin(IVIg) Therapy Production by Region (2021-2032)
1.3.3 World Intravenous Immunoglobulin(IVIg) Therapy Average Price by Region (2021-2032)
1.3.4 North America Intravenous Immunoglobulin(IVIg) Therapy Production (2021-2032)
1.3.5 Europe Intravenous Immunoglobulin(IVIg) Therapy Production (2021-2032)
1.3.6 China Intravenous Immunoglobulin(IVIg) Therapy Production (2021-2032)
1.3.7 Japan Intravenous Immunoglobulin(IVIg) Therapy Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Intravenous Immunoglobulin(IVIg) Therapy Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Intravenous Immunoglobulin(IVIg) Therapy Major Market Trends
2 DEMAND SUMMARY
2.1 World Intravenous Immunoglobulin(IVIg) Therapy Demand (2021-2032)
2.2 World Intravenous Immunoglobulin(IVIg) Therapy Consumption by Region
2.2.1 World Intravenous Immunoglobulin(IVIg) Therapy Consumption by Region (2021-2026)
2.2.2 World Intravenous Immunoglobulin(IVIg) Therapy Consumption Forecast by Region (2027-2032)
2.3 United States Intravenous Immunoglobulin(IVIg) Therapy Consumption (2021-2032)
2.4 China Intravenous Immunoglobulin(IVIg) Therapy Consumption (2021-2032)
2.5 Europe Intravenous Immunoglobulin(IVIg) Therapy Consumption (2021-2032)
2.6 Japan Intravenous Immunoglobulin(IVIg) Therapy Consumption (2021-2032)
2.7 South Korea Intravenous Immunoglobulin(IVIg) Therapy Consumption (2021-2032)
2.8 ASEAN Intravenous Immunoglobulin(IVIg) Therapy Consumption (2021-2032)
2.9 India Intravenous Immunoglobulin(IVIg) Therapy Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Intravenous Immunoglobulin(IVIg) Therapy Production Value by Manufacturer (2021-2026)
3.2 World Intravenous Immunoglobulin(IVIg) Therapy Production by Manufacturer (2021-2026)
3.3 World Intravenous Immunoglobulin(IVIg) Therapy Average Price by Manufacturer (2021-2026)
3.4 Intravenous Immunoglobulin(IVIg) Therapy Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Intravenous Immunoglobulin(IVIg) Therapy Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Intravenous Immunoglobulin(IVIg) Therapy in 2025
3.5.3 Global Concentration Ratios (CR8) for Intravenous Immunoglobulin(IVIg) Therapy in 2025
3.6 Intravenous Immunoglobulin(IVIg) Therapy Market: Overall Company Footprint Analysis
3.6.1 Intravenous Immunoglobulin(IVIg) Therapy Market: Region Footprint
3.6.2 Intravenous Immunoglobulin(IVIg) Therapy Market: Company Product Type Footprint
3.6.3 Intravenous Immunoglobulin(IVIg) Therapy Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Intravenous Immunoglobulin(IVIg) Therapy Production Value Comparison
4.1.1 United States VS China: Intravenous Immunoglobulin(IVIg) Therapy Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Intravenous Immunoglobulin(IVIg) Therapy Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Intravenous Immunoglobulin(IVIg) Therapy Production Comparison
4.2.1 United States VS China: Intravenous Immunoglobulin(IVIg) Therapy Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Intravenous Immunoglobulin(IVIg) Therapy Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Intravenous Immunoglobulin(IVIg) Therapy Consumption Comparison
4.3.1 United States VS China: Intravenous Immunoglobulin(IVIg) Therapy Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Intravenous Immunoglobulin(IVIg) Therapy Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Intravenous Immunoglobulin(IVIg) Therapy Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Intravenous Immunoglobulin(IVIg) Therapy Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Intravenous Immunoglobulin(IVIg) Therapy Production Value (2021-2026)
4.4.3 United States Based Manufacturers Intravenous Immunoglobulin(IVIg) Therapy Production (2021-2026)
4.5 China Based Intravenous Immunoglobulin(IVIg) Therapy Manufacturers and Market Share
4.5.1 China Based Intravenous Immunoglobulin(IVIg) Therapy Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Intravenous Immunoglobulin(IVIg) Therapy Production Value (2021-2026)
4.5.3 China Based Manufacturers Intravenous Immunoglobulin(IVIg) Therapy Production (2021-2026)
4.6 Rest of World Based Intravenous Immunoglobulin(IVIg) Therapy Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Intravenous Immunoglobulin(IVIg) Therapy Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Intravenous Immunoglobulin(IVIg) Therapy Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Intravenous Immunoglobulin(IVIg) Therapy Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Intravenous Immunoglobulin(IVIg) Therapy Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Liquid
5.2.2 Powder
5.3 Market Segment by Type
5.3.1 World Intravenous Immunoglobulin(IVIg) Therapy Production by Type (2021-2032)
5.3.2 World Intravenous Immunoglobulin(IVIg) Therapy Production Value by Type (2021-2032)
5.3.3 World Intravenous Immunoglobulin(IVIg) Therapy Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY PRODUCT CONCENTRATION
6.1 World Intravenous Immunoglobulin(IVIg) Therapy Market Size Overview by Product Concentration: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Product Concentration
6.2.1 Low Concentration
6.2.2 Medium Concentration
6.2.3 High Concentration
6.3 Market Segment by Product Concentration
6.3.1 World Intravenous Immunoglobulin(IVIg) Therapy Production by Product Concentration (2021-2032)
6.3.2 World Intravenous Immunoglobulin(IVIg) Therapy Production Value by Product Concentration (2021-2032)
6.3.3 World Intravenous Immunoglobulin(IVIg) Therapy Average Price by Product Concentration (2021-2032)
7 MARKET ANALYSIS BY TREATMENT SETTING
7.1 World Intravenous Immunoglobulin(IVIg) Therapy Market Size Overview by Treatment Setting: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Treatment Setting
7.2.1 Acute Therapy
7.2.2 Maintenance Therapy
7.2.3 Critical Care
7.3 Market Segment by Treatment Setting
7.3.1 World Intravenous Immunoglobulin(IVIg) Therapy Production by Treatment Setting (2021-2032)
7.3.2 World Intravenous Immunoglobulin(IVIg) Therapy Production Value by Treatment Setting (2021-2032)
7.3.3 World Intravenous Immunoglobulin(IVIg) Therapy Average Price by Treatment Setting (2021-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Intravenous Immunoglobulin(IVIg) Therapy Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Immunodeficiency
8.2.2 Autoimmune Disease
8.2.3 Acute Infection
8.2.4 Others
8.3 Market Segment by Application
8.3.1 World Intravenous Immunoglobulin(IVIg) Therapy Production by Application (2021-2032)
8.3.2 World Intravenous Immunoglobulin(IVIg) Therapy Production Value by Application (2021-2032)
8.3.3 World Intravenous Immunoglobulin(IVIg) Therapy Average Price by Application (2021-2032)
9 COMPANY PROFILES
9.1 Takeda
9.1.1 Takeda Details
9.1.2 Takeda Major Business
9.1.3 Takeda Intravenous Immunoglobulin(IVIg) Therapy Product and Services
9.1.4 Takeda Intravenous Immunoglobulin(IVIg) Therapy Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.1.5 Takeda Recent Developments/Updates
9.1.6 Takeda Competitive Strengths & Weaknesses
9.2 CSL
9.2.1 CSL Details
9.2.2 CSL Major Business
9.2.3 CSL Intravenous Immunoglobulin(IVIg) Therapy Product and Services
9.2.4 CSL Intravenous Immunoglobulin(IVIg) Therapy Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.2.5 CSL Recent Developments/Updates
9.2.6 CSL Competitive Strengths & Weaknesses
9.3 Grifols
9.3.1 Grifols Details
9.3.2 Grifols Major Business
9.3.3 Grifols Intravenous Immunoglobulin(IVIg) Therapy Product and Services
9.3.4 Grifols Intravenous Immunoglobulin(IVIg) Therapy Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.3.5 Grifols Recent Developments/Updates
9.3.6 Grifols Competitive Strengths & Weaknesses
9.4 Octapharma
9.4.1 Octapharma Details
9.4.2 Octapharma Major Business
9.4.3 Octapharma Intravenous Immunoglobulin(IVIg) Therapy Product and Services
9.4.4 Octapharma Intravenous Immunoglobulin(IVIg) Therapy Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.4.5 Octapharma Recent Developments/Updates
9.4.6 Octapharma Competitive Strengths & Weaknesses
9.5 Kedrion
9.5.1 Kedrion Details
9.5.2 Kedrion Major Business
9.5.3 Kedrion Intravenous Immunoglobulin(IVIg) Therapy Product and Services
9.5.4 Kedrion Intravenous Immunoglobulin(IVIg) Therapy Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.5.5 Kedrion Recent Developments/Updates
9.5.6 Kedrion Competitive Strengths & Weaknesses
9.6 LFB Group
9.6.1 LFB Group Details
9.6.2 LFB Group Major Business
9.6.3 LFB Group Intravenous Immunoglobulin(IVIg) Therapy Product and Services
9.6.4 LFB Group Intravenous Immunoglobulin(IVIg) Therapy Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.6.5 LFB Group Recent Developments/Updates
9.6.6 LFB Group Competitive Strengths & Weaknesses
9.7 Biotest
9.7.1 Biotest Details
9.7.2 Biotest Major Business
9.7.3 Biotest Intravenous Immunoglobulin(IVIg) Therapy Product and Services
9.7.4 Biotest Intravenous Immunoglobulin(IVIg) Therapy Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.7.5 Biotest Recent Developments/Updates
9.7.6 Biotest Competitive Strengths & Weaknesses
9.8 BPL
9.8.1 BPL Details
9.8.2 BPL Major Business
9.8.3 BPL Intravenous Immunoglobulin(IVIg) Therapy Product and Services
9.8.4 BPL Intravenous Immunoglobulin(IVIg) Therapy Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.8.5 BPL Recent Developments/Updates
9.8.6 BPL Competitive Strengths & Weaknesses
9.9 RAAS
9.9.1 RAAS Details
9.9.2 RAAS Major Business
9.9.3 RAAS Intravenous Immunoglobulin(IVIg) Therapy Product and Services
9.9.4 RAAS Intravenous Immunoglobulin(IVIg) Therapy Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.9.5 RAAS Recent Developments/Updates
9.9.6 RAAS Competitive Strengths & Weaknesses
9.10 CBPO
9.10.1 CBPO Details
9.10.2 CBPO Major Business
9.10.3 CBPO Intravenous Immunoglobulin(IVIg) Therapy Product and Services
9.10.4 CBPO Intravenous Immunoglobulin(IVIg) Therapy Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.10.5 CBPO Recent Developments/Updates
9.10.6 CBPO Competitive Strengths & Weaknesses
9.11 Hualan Bio
9.11.1 Hualan Bio Details
9.11.2 Hualan Bio Major Business
9.11.3 Hualan Bio Intravenous Immunoglobulin(IVIg) Therapy Product and Services
9.11.4 Hualan Bio Intravenous Immunoglobulin(IVIg) Therapy Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.11.5 Hualan Bio Recent Developments/Updates
9.11.6 Hualan Bio Competitive Strengths & Weaknesses
9.12 Tiantan Bio
9.12.1 Tiantan Bio Details
9.12.2 Tiantan Bio Major Business
9.12.3 Tiantan Bio Intravenous Immunoglobulin(IVIg) Therapy Product and Services
9.12.4 Tiantan Bio Intravenous Immunoglobulin(IVIg) Therapy Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.12.5 Tiantan Bio Recent Developments/Updates
9.12.6 Tiantan Bio Competitive Strengths & Weaknesses
9.13 Shuanglin Bio
9.13.1 Shuanglin Bio Details
9.13.2 Shuanglin Bio Major Business
9.13.3 Shuanglin Bio Intravenous Immunoglobulin(IVIg) Therapy Product and Services
9.13.4 Shuanglin Bio Intravenous Immunoglobulin(IVIg) Therapy Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.13.5 Shuanglin Bio Recent Developments/Updates
9.13.6 Shuanglin Bio Competitive Strengths & Weaknesses
9.14 Boya Bio
9.14.1 Boya Bio Details
9.14.2 Boya Bio Major Business
9.14.3 Boya Bio Intravenous Immunoglobulin(IVIg) Therapy Product and Services
9.14.4 Boya Bio Intravenous Immunoglobulin(IVIg) Therapy Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.14.5 Boya Bio Recent Developments/Updates
9.14.6 Boya Bio Competitive Strengths & Weaknesses
9.15 Yuanda Shuyang
9.15.1 Yuanda Shuyang Details
9.15.2 Yuanda Shuyang Major Business
9.15.3 Yuanda Shuyang Intravenous Immunoglobulin(IVIg) Therapy Product and Services
9.15.4 Yuanda Shuyang Intravenous Immunoglobulin(IVIg) Therapy Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.15.5 Yuanda Shuyang Recent Developments/Updates
9.15.6 Yuanda Shuyang Competitive Strengths & Weaknesses
9.16 Weiguang Bio
9.16.1 Weiguang Bio Details
9.16.2 Weiguang Bio Major Business
9.16.3 Weiguang Bio Intravenous Immunoglobulin(IVIg) Therapy Product and Services
9.16.4 Weiguang Bio Intravenous Immunoglobulin(IVIg) Therapy Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.16.5 Weiguang Bio Recent Developments/Updates
9.16.6 Weiguang Bio Competitive Strengths & Weaknesses
9.17 Nanyue Bio
9.17.1 Nanyue Bio Details
9.17.2 Nanyue Bio Major Business
9.17.3 Nanyue Bio Intravenous Immunoglobulin(IVIg) Therapy Product and Services
9.17.4 Nanyue Bio Intravenous Immunoglobulin(IVIg) Therapy Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.17.5 Nanyue Bio Recent Developments/Updates
9.17.6 Nanyue Bio Competitive Strengths & Weaknesses
9.18 KM Biologics
9.18.1 KM Biologics Details
9.18.2 KM Biologics Major Business
9.18.3 KM Biologics Intravenous Immunoglobulin(IVIg) Therapy Product and Services
9.18.4 KM Biologics Intravenous Immunoglobulin(IVIg) Therapy Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.18.5 KM Biologics Recent Developments/Updates
9.18.6 KM Biologics Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Intravenous Immunoglobulin(IVIg) Therapy Industry Chain
10.2 Intravenous Immunoglobulin(IVIg) Therapy Upstream Analysis
10.2.1 Intravenous Immunoglobulin(IVIg) Therapy Core Raw Materials
10.2.2 Main Manufacturers of Intravenous Immunoglobulin(IVIg) Therapy Core Raw Materials
10.3 Midstream Analysis
10.4 Downstream Analysis
10.5 Intravenous Immunoglobulin(IVIg) Therapy Production Mode
10.6 Intravenous Immunoglobulin(IVIg) Therapy Procurement Model
10.7 Intravenous Immunoglobulin(IVIg) Therapy Industry Sales Model and Sales Channels
10.7.1 Intravenous Immunoglobulin(IVIg) Therapy Sales Model
10.7.2 Intravenous Immunoglobulin(IVIg) Therapy Typical Distributors
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Intravenous Immunoglobulin(IVIg) Therapy Introduction
1.2 World Intravenous Immunoglobulin(IVIg) Therapy Supply & Forecast
1.2.1 World Intravenous Immunoglobulin(IVIg) Therapy Production Value (2021 & 2025 & 2032)
1.2.2 World Intravenous Immunoglobulin(IVIg) Therapy Production (2021-2032)
1.2.3 World Intravenous Immunoglobulin(IVIg) Therapy Pricing Trends (2021-2032)
1.3 World Intravenous Immunoglobulin(IVIg) Therapy Production by Region (Based on Production Site)
1.3.1 World Intravenous Immunoglobulin(IVIg) Therapy Production Value by Region (2021-2032)
1.3.2 World Intravenous Immunoglobulin(IVIg) Therapy Production by Region (2021-2032)
1.3.3 World Intravenous Immunoglobulin(IVIg) Therapy Average Price by Region (2021-2032)
1.3.4 North America Intravenous Immunoglobulin(IVIg) Therapy Production (2021-2032)
1.3.5 Europe Intravenous Immunoglobulin(IVIg) Therapy Production (2021-2032)
1.3.6 China Intravenous Immunoglobulin(IVIg) Therapy Production (2021-2032)
1.3.7 Japan Intravenous Immunoglobulin(IVIg) Therapy Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Intravenous Immunoglobulin(IVIg) Therapy Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Intravenous Immunoglobulin(IVIg) Therapy Major Market Trends
2 DEMAND SUMMARY
2.1 World Intravenous Immunoglobulin(IVIg) Therapy Demand (2021-2032)
2.2 World Intravenous Immunoglobulin(IVIg) Therapy Consumption by Region
2.2.1 World Intravenous Immunoglobulin(IVIg) Therapy Consumption by Region (2021-2026)
2.2.2 World Intravenous Immunoglobulin(IVIg) Therapy Consumption Forecast by Region (2027-2032)
2.3 United States Intravenous Immunoglobulin(IVIg) Therapy Consumption (2021-2032)
2.4 China Intravenous Immunoglobulin(IVIg) Therapy Consumption (2021-2032)
2.5 Europe Intravenous Immunoglobulin(IVIg) Therapy Consumption (2021-2032)
2.6 Japan Intravenous Immunoglobulin(IVIg) Therapy Consumption (2021-2032)
2.7 South Korea Intravenous Immunoglobulin(IVIg) Therapy Consumption (2021-2032)
2.8 ASEAN Intravenous Immunoglobulin(IVIg) Therapy Consumption (2021-2032)
2.9 India Intravenous Immunoglobulin(IVIg) Therapy Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Intravenous Immunoglobulin(IVIg) Therapy Production Value by Manufacturer (2021-2026)
3.2 World Intravenous Immunoglobulin(IVIg) Therapy Production by Manufacturer (2021-2026)
3.3 World Intravenous Immunoglobulin(IVIg) Therapy Average Price by Manufacturer (2021-2026)
3.4 Intravenous Immunoglobulin(IVIg) Therapy Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Intravenous Immunoglobulin(IVIg) Therapy Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Intravenous Immunoglobulin(IVIg) Therapy in 2025
3.5.3 Global Concentration Ratios (CR8) for Intravenous Immunoglobulin(IVIg) Therapy in 2025
3.6 Intravenous Immunoglobulin(IVIg) Therapy Market: Overall Company Footprint Analysis
3.6.1 Intravenous Immunoglobulin(IVIg) Therapy Market: Region Footprint
3.6.2 Intravenous Immunoglobulin(IVIg) Therapy Market: Company Product Type Footprint
3.6.3 Intravenous Immunoglobulin(IVIg) Therapy Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Intravenous Immunoglobulin(IVIg) Therapy Production Value Comparison
4.1.1 United States VS China: Intravenous Immunoglobulin(IVIg) Therapy Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Intravenous Immunoglobulin(IVIg) Therapy Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Intravenous Immunoglobulin(IVIg) Therapy Production Comparison
4.2.1 United States VS China: Intravenous Immunoglobulin(IVIg) Therapy Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Intravenous Immunoglobulin(IVIg) Therapy Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Intravenous Immunoglobulin(IVIg) Therapy Consumption Comparison
4.3.1 United States VS China: Intravenous Immunoglobulin(IVIg) Therapy Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Intravenous Immunoglobulin(IVIg) Therapy Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Intravenous Immunoglobulin(IVIg) Therapy Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Intravenous Immunoglobulin(IVIg) Therapy Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Intravenous Immunoglobulin(IVIg) Therapy Production Value (2021-2026)
4.4.3 United States Based Manufacturers Intravenous Immunoglobulin(IVIg) Therapy Production (2021-2026)
4.5 China Based Intravenous Immunoglobulin(IVIg) Therapy Manufacturers and Market Share
4.5.1 China Based Intravenous Immunoglobulin(IVIg) Therapy Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Intravenous Immunoglobulin(IVIg) Therapy Production Value (2021-2026)
4.5.3 China Based Manufacturers Intravenous Immunoglobulin(IVIg) Therapy Production (2021-2026)
4.6 Rest of World Based Intravenous Immunoglobulin(IVIg) Therapy Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Intravenous Immunoglobulin(IVIg) Therapy Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Intravenous Immunoglobulin(IVIg) Therapy Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Intravenous Immunoglobulin(IVIg) Therapy Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Intravenous Immunoglobulin(IVIg) Therapy Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Liquid
5.2.2 Powder
5.3 Market Segment by Type
5.3.1 World Intravenous Immunoglobulin(IVIg) Therapy Production by Type (2021-2032)
5.3.2 World Intravenous Immunoglobulin(IVIg) Therapy Production Value by Type (2021-2032)
5.3.3 World Intravenous Immunoglobulin(IVIg) Therapy Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY PRODUCT CONCENTRATION
6.1 World Intravenous Immunoglobulin(IVIg) Therapy Market Size Overview by Product Concentration: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Product Concentration
6.2.1 Low Concentration
6.2.2 Medium Concentration
6.2.3 High Concentration
6.3 Market Segment by Product Concentration
6.3.1 World Intravenous Immunoglobulin(IVIg) Therapy Production by Product Concentration (2021-2032)
6.3.2 World Intravenous Immunoglobulin(IVIg) Therapy Production Value by Product Concentration (2021-2032)
6.3.3 World Intravenous Immunoglobulin(IVIg) Therapy Average Price by Product Concentration (2021-2032)
7 MARKET ANALYSIS BY TREATMENT SETTING
7.1 World Intravenous Immunoglobulin(IVIg) Therapy Market Size Overview by Treatment Setting: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Treatment Setting
7.2.1 Acute Therapy
7.2.2 Maintenance Therapy
7.2.3 Critical Care
7.3 Market Segment by Treatment Setting
7.3.1 World Intravenous Immunoglobulin(IVIg) Therapy Production by Treatment Setting (2021-2032)
7.3.2 World Intravenous Immunoglobulin(IVIg) Therapy Production Value by Treatment Setting (2021-2032)
7.3.3 World Intravenous Immunoglobulin(IVIg) Therapy Average Price by Treatment Setting (2021-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Intravenous Immunoglobulin(IVIg) Therapy Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Immunodeficiency
8.2.2 Autoimmune Disease
8.2.3 Acute Infection
8.2.4 Others
8.3 Market Segment by Application
8.3.1 World Intravenous Immunoglobulin(IVIg) Therapy Production by Application (2021-2032)
8.3.2 World Intravenous Immunoglobulin(IVIg) Therapy Production Value by Application (2021-2032)
8.3.3 World Intravenous Immunoglobulin(IVIg) Therapy Average Price by Application (2021-2032)
9 COMPANY PROFILES
9.1 Takeda
9.1.1 Takeda Details
9.1.2 Takeda Major Business
9.1.3 Takeda Intravenous Immunoglobulin(IVIg) Therapy Product and Services
9.1.4 Takeda Intravenous Immunoglobulin(IVIg) Therapy Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.1.5 Takeda Recent Developments/Updates
9.1.6 Takeda Competitive Strengths & Weaknesses
9.2 CSL
9.2.1 CSL Details
9.2.2 CSL Major Business
9.2.3 CSL Intravenous Immunoglobulin(IVIg) Therapy Product and Services
9.2.4 CSL Intravenous Immunoglobulin(IVIg) Therapy Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.2.5 CSL Recent Developments/Updates
9.2.6 CSL Competitive Strengths & Weaknesses
9.3 Grifols
9.3.1 Grifols Details
9.3.2 Grifols Major Business
9.3.3 Grifols Intravenous Immunoglobulin(IVIg) Therapy Product and Services
9.3.4 Grifols Intravenous Immunoglobulin(IVIg) Therapy Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.3.5 Grifols Recent Developments/Updates
9.3.6 Grifols Competitive Strengths & Weaknesses
9.4 Octapharma
9.4.1 Octapharma Details
9.4.2 Octapharma Major Business
9.4.3 Octapharma Intravenous Immunoglobulin(IVIg) Therapy Product and Services
9.4.4 Octapharma Intravenous Immunoglobulin(IVIg) Therapy Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.4.5 Octapharma Recent Developments/Updates
9.4.6 Octapharma Competitive Strengths & Weaknesses
9.5 Kedrion
9.5.1 Kedrion Details
9.5.2 Kedrion Major Business
9.5.3 Kedrion Intravenous Immunoglobulin(IVIg) Therapy Product and Services
9.5.4 Kedrion Intravenous Immunoglobulin(IVIg) Therapy Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.5.5 Kedrion Recent Developments/Updates
9.5.6 Kedrion Competitive Strengths & Weaknesses
9.6 LFB Group
9.6.1 LFB Group Details
9.6.2 LFB Group Major Business
9.6.3 LFB Group Intravenous Immunoglobulin(IVIg) Therapy Product and Services
9.6.4 LFB Group Intravenous Immunoglobulin(IVIg) Therapy Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.6.5 LFB Group Recent Developments/Updates
9.6.6 LFB Group Competitive Strengths & Weaknesses
9.7 Biotest
9.7.1 Biotest Details
9.7.2 Biotest Major Business
9.7.3 Biotest Intravenous Immunoglobulin(IVIg) Therapy Product and Services
9.7.4 Biotest Intravenous Immunoglobulin(IVIg) Therapy Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.7.5 Biotest Recent Developments/Updates
9.7.6 Biotest Competitive Strengths & Weaknesses
9.8 BPL
9.8.1 BPL Details
9.8.2 BPL Major Business
9.8.3 BPL Intravenous Immunoglobulin(IVIg) Therapy Product and Services
9.8.4 BPL Intravenous Immunoglobulin(IVIg) Therapy Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.8.5 BPL Recent Developments/Updates
9.8.6 BPL Competitive Strengths & Weaknesses
9.9 RAAS
9.9.1 RAAS Details
9.9.2 RAAS Major Business
9.9.3 RAAS Intravenous Immunoglobulin(IVIg) Therapy Product and Services
9.9.4 RAAS Intravenous Immunoglobulin(IVIg) Therapy Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.9.5 RAAS Recent Developments/Updates
9.9.6 RAAS Competitive Strengths & Weaknesses
9.10 CBPO
9.10.1 CBPO Details
9.10.2 CBPO Major Business
9.10.3 CBPO Intravenous Immunoglobulin(IVIg) Therapy Product and Services
9.10.4 CBPO Intravenous Immunoglobulin(IVIg) Therapy Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.10.5 CBPO Recent Developments/Updates
9.10.6 CBPO Competitive Strengths & Weaknesses
9.11 Hualan Bio
9.11.1 Hualan Bio Details
9.11.2 Hualan Bio Major Business
9.11.3 Hualan Bio Intravenous Immunoglobulin(IVIg) Therapy Product and Services
9.11.4 Hualan Bio Intravenous Immunoglobulin(IVIg) Therapy Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.11.5 Hualan Bio Recent Developments/Updates
9.11.6 Hualan Bio Competitive Strengths & Weaknesses
9.12 Tiantan Bio
9.12.1 Tiantan Bio Details
9.12.2 Tiantan Bio Major Business
9.12.3 Tiantan Bio Intravenous Immunoglobulin(IVIg) Therapy Product and Services
9.12.4 Tiantan Bio Intravenous Immunoglobulin(IVIg) Therapy Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.12.5 Tiantan Bio Recent Developments/Updates
9.12.6 Tiantan Bio Competitive Strengths & Weaknesses
9.13 Shuanglin Bio
9.13.1 Shuanglin Bio Details
9.13.2 Shuanglin Bio Major Business
9.13.3 Shuanglin Bio Intravenous Immunoglobulin(IVIg) Therapy Product and Services
9.13.4 Shuanglin Bio Intravenous Immunoglobulin(IVIg) Therapy Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.13.5 Shuanglin Bio Recent Developments/Updates
9.13.6 Shuanglin Bio Competitive Strengths & Weaknesses
9.14 Boya Bio
9.14.1 Boya Bio Details
9.14.2 Boya Bio Major Business
9.14.3 Boya Bio Intravenous Immunoglobulin(IVIg) Therapy Product and Services
9.14.4 Boya Bio Intravenous Immunoglobulin(IVIg) Therapy Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.14.5 Boya Bio Recent Developments/Updates
9.14.6 Boya Bio Competitive Strengths & Weaknesses
9.15 Yuanda Shuyang
9.15.1 Yuanda Shuyang Details
9.15.2 Yuanda Shuyang Major Business
9.15.3 Yuanda Shuyang Intravenous Immunoglobulin(IVIg) Therapy Product and Services
9.15.4 Yuanda Shuyang Intravenous Immunoglobulin(IVIg) Therapy Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.15.5 Yuanda Shuyang Recent Developments/Updates
9.15.6 Yuanda Shuyang Competitive Strengths & Weaknesses
9.16 Weiguang Bio
9.16.1 Weiguang Bio Details
9.16.2 Weiguang Bio Major Business
9.16.3 Weiguang Bio Intravenous Immunoglobulin(IVIg) Therapy Product and Services
9.16.4 Weiguang Bio Intravenous Immunoglobulin(IVIg) Therapy Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.16.5 Weiguang Bio Recent Developments/Updates
9.16.6 Weiguang Bio Competitive Strengths & Weaknesses
9.17 Nanyue Bio
9.17.1 Nanyue Bio Details
9.17.2 Nanyue Bio Major Business
9.17.3 Nanyue Bio Intravenous Immunoglobulin(IVIg) Therapy Product and Services
9.17.4 Nanyue Bio Intravenous Immunoglobulin(IVIg) Therapy Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.17.5 Nanyue Bio Recent Developments/Updates
9.17.6 Nanyue Bio Competitive Strengths & Weaknesses
9.18 KM Biologics
9.18.1 KM Biologics Details
9.18.2 KM Biologics Major Business
9.18.3 KM Biologics Intravenous Immunoglobulin(IVIg) Therapy Product and Services
9.18.4 KM Biologics Intravenous Immunoglobulin(IVIg) Therapy Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.18.5 KM Biologics Recent Developments/Updates
9.18.6 KM Biologics Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Intravenous Immunoglobulin(IVIg) Therapy Industry Chain
10.2 Intravenous Immunoglobulin(IVIg) Therapy Upstream Analysis
10.2.1 Intravenous Immunoglobulin(IVIg) Therapy Core Raw Materials
10.2.2 Main Manufacturers of Intravenous Immunoglobulin(IVIg) Therapy Core Raw Materials
10.3 Midstream Analysis
10.4 Downstream Analysis
10.5 Intravenous Immunoglobulin(IVIg) Therapy Production Mode
10.6 Intravenous Immunoglobulin(IVIg) Therapy Procurement Model
10.7 Intravenous Immunoglobulin(IVIg) Therapy Industry Sales Model and Sales Channels
10.7.1 Intravenous Immunoglobulin(IVIg) Therapy Sales Model
10.7.2 Intravenous Immunoglobulin(IVIg) Therapy Typical Distributors
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World Intravenous Immunoglobulin(IVIg) Therapy Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Intravenous Immunoglobulin(IVIg) Therapy Production Value by Region (2021-2026) & (USD Million)
Table 3. World Intravenous Immunoglobulin(IVIg) Therapy Production Value by Region (2027-2032) & (USD Million)
Table 4. World Intravenous Immunoglobulin(IVIg) Therapy Production Value Market Share by Region (2021-2026)
Table 5. World Intravenous Immunoglobulin(IVIg) Therapy Production Value Market Share by Region (2027-2032)
Table 6. World Intravenous Immunoglobulin(IVIg) Therapy Production by Region (2021-2026) & (K Units)
Table 7. World Intravenous Immunoglobulin(IVIg) Therapy Production by Region (2027-2032) & (K Units)
Table 8. World Intravenous Immunoglobulin(IVIg) Therapy Production Market Share by Region (2021-2026)
Table 9. World Intravenous Immunoglobulin(IVIg) Therapy Production Market Share by Region (2027-2032)
Table 10. World Intravenous Immunoglobulin(IVIg) Therapy Average Price by Region (2021-2026) & (US$/Unit)
Table 11. World Intravenous Immunoglobulin(IVIg) Therapy Average Price by Region (2027-2032) & (US$/Unit)
Table 12. Intravenous Immunoglobulin(IVIg) Therapy Major Market Trends
Table 13. World Intravenous Immunoglobulin(IVIg) Therapy Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (K Units)
Table 14. World Intravenous Immunoglobulin(IVIg) Therapy Consumption by Region (2021-2026) & (K Units)
Table 15. World Intravenous Immunoglobulin(IVIg) Therapy Consumption Forecast by Region (2027-2032) & (K Units)
Table 16. World Intravenous Immunoglobulin(IVIg) Therapy Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Intravenous Immunoglobulin(IVIg) Therapy Producers in 2025
Table 18. World Intravenous Immunoglobulin(IVIg) Therapy Production by Manufacturer (2021-2026) & (K Units)
Table 19. Production Market Share of Key Intravenous Immunoglobulin(IVIg) Therapy Producers in 2025
Table 20. World Intravenous Immunoglobulin(IVIg) Therapy Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 21. Global Intravenous Immunoglobulin(IVIg) Therapy Company Evaluation Quadrant
Table 22. World Intravenous Immunoglobulin(IVIg) Therapy Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Intravenous Immunoglobulin(IVIg) Therapy Production Site of Key Manufacturer
Table 24. Intravenous Immunoglobulin(IVIg) Therapy Market: Company Product Type Footprint
Table 25. Intravenous Immunoglobulin(IVIg) Therapy Market: Company Product Application Footprint
Table 26. Intravenous Immunoglobulin(IVIg) Therapy Competitive Factors
Table 27. Intravenous Immunoglobulin(IVIg) Therapy New Entrant and Capacity Expansion Plans
Table 28. Intravenous Immunoglobulin(IVIg) Therapy Mergers & Acquisitions Activity
Table 29. United States VS China Intravenous Immunoglobulin(IVIg) Therapy Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Intravenous Immunoglobulin(IVIg) Therapy Production Comparison, (2021 & 2025 & 2032) & (K Units)
Table 31. United States VS China Intravenous Immunoglobulin(IVIg) Therapy Consumption Comparison, (2021 & 2025 & 2032) & (K Units)
Table 32. United States Based Intravenous Immunoglobulin(IVIg) Therapy Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Intravenous Immunoglobulin(IVIg) Therapy Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Intravenous Immunoglobulin(IVIg) Therapy Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Intravenous Immunoglobulin(IVIg) Therapy Production (2021-2026) & (K Units)
Table 36. United States Based Manufacturers Intravenous Immunoglobulin(IVIg) Therapy Production Market Share (2021-2026)
Table 37. China Based Intravenous Immunoglobulin(IVIg) Therapy Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Intravenous Immunoglobulin(IVIg) Therapy Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Intravenous Immunoglobulin(IVIg) Therapy Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Intravenous Immunoglobulin(IVIg) Therapy Production, (2021-2026) & (K Units)
Table 41. China Based Manufacturers Intravenous Immunoglobulin(IVIg) Therapy Production Market Share (2021-2026)
Table 42. Rest of World Based Intravenous Immunoglobulin(IVIg) Therapy Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Intravenous Immunoglobulin(IVIg) Therapy Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Intravenous Immunoglobulin(IVIg) Therapy Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Intravenous Immunoglobulin(IVIg) Therapy Production, (2021-2026) & (K Units)
Table 46. Rest of World Based Manufacturers Intravenous Immunoglobulin(IVIg) Therapy Production Market Share (2021-2026)
Table 47. World Intravenous Immunoglobulin(IVIg) Therapy Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Intravenous Immunoglobulin(IVIg) Therapy Production by Type (2021-2026) & (K Units)
Table 49. World Intravenous Immunoglobulin(IVIg) Therapy Production by Type (2027-2032) & (K Units)
Table 50. World Intravenous Immunoglobulin(IVIg) Therapy Production Value by Type (2021-2026) & (USD Million)
Table 51. World Intravenous Immunoglobulin(IVIg) Therapy Production Value by Type (2027-2032) & (USD Million)
Table 52. World Intravenous Immunoglobulin(IVIg) Therapy Average Price by Type (2021-2026) & (US$/Unit)
Table 53. World Intravenous Immunoglobulin(IVIg) Therapy Average Price by Type (2027-2032) & (US$/Unit)
Table 54. World Intravenous Immunoglobulin(IVIg) Therapy Production Value by Product Concentration, (USD Million), 2021 & 2025 & 2032
Table 55. World Intravenous Immunoglobulin(IVIg) Therapy Production by Product Concentration (2021-2026) & (K Units)
Table 56. World Intravenous Immunoglobulin(IVIg) Therapy Production by Product Concentration (2027-2032) & (K Units)
Table 57. World Intravenous Immunoglobulin(IVIg) Therapy Production Value by Product Concentration (2021-2026) & (USD Million)
Table 58. World Intravenous Immunoglobulin(IVIg) Therapy Production Value by Product Concentration (2027-2032) & (USD Million)
Table 59. World Intravenous Immunoglobulin(IVIg) Therapy Average Price by Product Concentration (2021-2026) & (US$/Unit)
Table 60. World Intravenous Immunoglobulin(IVIg) Therapy Average Price by Product Concentration (2027-2032) & (US$/Unit)
Table 61. World Intravenous Immunoglobulin(IVIg) Therapy Production Value by Treatment Setting, (USD Million), 2021 & 2025 & 2032
Table 62. World Intravenous Immunoglobulin(IVIg) Therapy Production by Treatment Setting (2021-2026) & (K Units)
Table 63. World Intravenous Immunoglobulin(IVIg) Therapy Production by Treatment Setting (2027-2032) & (K Units)
Table 64. World Intravenous Immunoglobulin(IVIg) Therapy Production Value by Treatment Setting (2021-2026) & (USD Million)
Table 65. World Intravenous Immunoglobulin(IVIg) Therapy Production Value by Treatment Setting (2027-2032) & (USD Million)
Table 66. World Intravenous Immunoglobulin(IVIg) Therapy Average Price by Treatment Setting (2021-2026) & (US$/Unit)
Table 67. World Intravenous Immunoglobulin(IVIg) Therapy Average Price by Treatment Setting (2027-2032) & (US$/Unit)
Table 68. World Intravenous Immunoglobulin(IVIg) Therapy Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 69. World Intravenous Immunoglobulin(IVIg) Therapy Production by Application (2021-2026) & (K Units)
Table 70. World Intravenous Immunoglobulin(IVIg) Therapy Production by Application (2027-2032) & (K Units)
Table 71. World Intravenous Immunoglobulin(IVIg) Therapy Production Value by Application (2021-2026) & (USD Million)
Table 72. World Intravenous Immunoglobulin(IVIg) Therapy Production Value by Application (2027-2032) & (USD Million)
Table 73. World Intravenous Immunoglobulin(IVIg) Therapy Average Price by Application (2021-2026) & (US$/Unit)
Table 74. World Intravenous Immunoglobulin(IVIg) Therapy Average Price by Application (2027-2032) & (US$/Unit)
Table 75. Takeda Basic Information, Manufacturing Base and Competitors
Table 76. Takeda Major Business
Table 77. Takeda Intravenous Immunoglobulin(IVIg) Therapy Product and Services
Table 78. Takeda Intravenous Immunoglobulin(IVIg) Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. Takeda Recent Developments/Updates
Table 80. Takeda Competitive Strengths & Weaknesses
Table 81. CSL Basic Information, Manufacturing Base and Competitors
Table 82. CSL Major Business
Table 83. CSL Intravenous Immunoglobulin(IVIg) Therapy Product and Services
Table 84. CSL Intravenous Immunoglobulin(IVIg) Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. CSL Recent Developments/Updates
Table 86. CSL Competitive Strengths & Weaknesses
Table 87. Grifols Basic Information, Manufacturing Base and Competitors
Table 88. Grifols Major Business
Table 89. Grifols Intravenous Immunoglobulin(IVIg) Therapy Product and Services
Table 90. Grifols Intravenous Immunoglobulin(IVIg) Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 91. Grifols Recent Developments/Updates
Table 92. Grifols Competitive Strengths & Weaknesses
Table 93. Octapharma Basic Information, Manufacturing Base and Competitors
Table 94. Octapharma Major Business
Table 95. Octapharma Intravenous Immunoglobulin(IVIg) Therapy Product and Services
Table 96. Octapharma Intravenous Immunoglobulin(IVIg) Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 97. Octapharma Recent Developments/Updates
Table 98. Octapharma Competitive Strengths & Weaknesses
Table 99. Kedrion Basic Information, Manufacturing Base and Competitors
Table 100. Kedrion Major Business
Table 101. Kedrion Intravenous Immunoglobulin(IVIg) Therapy Product and Services
Table 102. Kedrion Intravenous Immunoglobulin(IVIg) Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 103. Kedrion Recent Developments/Updates
Table 104. Kedrion Competitive Strengths & Weaknesses
Table 105. LFB Group Basic Information, Manufacturing Base and Competitors
Table 106. LFB Group Major Business
Table 107. LFB Group Intravenous Immunoglobulin(IVIg) Therapy Product and Services
Table 108. LFB Group Intravenous Immunoglobulin(IVIg) Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 109. LFB Group Recent Developments/Updates
Table 110. LFB Group Competitive Strengths & Weaknesses
Table 111. Biotest Basic Information, Manufacturing Base and Competitors
Table 112. Biotest Major Business
Table 113. Biotest Intravenous Immunoglobulin(IVIg) Therapy Product and Services
Table 114. Biotest Intravenous Immunoglobulin(IVIg) Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 115. Biotest Recent Developments/Updates
Table 116. Biotest Competitive Strengths & Weaknesses
Table 117. BPL Basic Information, Manufacturing Base and Competitors
Table 118. BPL Major Business
Table 119. BPL Intravenous Immunoglobulin(IVIg) Therapy Product and Services
Table 120. BPL Intravenous Immunoglobulin(IVIg) Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 121. BPL Recent Developments/Updates
Table 122. BPL Competitive Strengths & Weaknesses
Table 123. RAAS Basic Information, Manufacturing Base and Competitors
Table 124. RAAS Major Business
Table 125. RAAS Intravenous Immunoglobulin(IVIg) Therapy Product and Services
Table 126. RAAS Intravenous Immunoglobulin(IVIg) Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 127. RAAS Recent Developments/Updates
Table 128. RAAS Competitive Strengths & Weaknesses
Table 129. CBPO Basic Information, Manufacturing Base and Competitors
Table 130. CBPO Major Business
Table 131. CBPO Intravenous Immunoglobulin(IVIg) Therapy Product and Services
Table 132. CBPO Intravenous Immunoglobulin(IVIg) Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 133. CBPO Recent Developments/Updates
Table 134. CBPO Competitive Strengths & Weaknesses
Table 135. Hualan Bio Basic Information, Manufacturing Base and Competitors
Table 136. Hualan Bio Major Business
Table 137. Hualan Bio Intravenous Immunoglobulin(IVIg) Therapy Product and Services
Table 138. Hualan Bio Intravenous Immunoglobulin(IVIg) Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 139. Hualan Bio Recent Developments/Updates
Table 140. Hualan Bio Competitive Strengths & Weaknesses
Table 141. Tiantan Bio Basic Information, Manufacturing Base and Competitors
Table 142. Tiantan Bio Major Business
Table 143. Tiantan Bio Intravenous Immunoglobulin(IVIg) Therapy Product and Services
Table 144. Tiantan Bio Intravenous Immunoglobulin(IVIg) Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 145. Tiantan Bio Recent Developments/Updates
Table 146. Tiantan Bio Competitive Strengths & Weaknesses
Table 147. Shuanglin Bio Basic Information, Manufacturing Base and Competitors
Table 148. Shuanglin Bio Major Business
Table 149. Shuanglin Bio Intravenous Immunoglobulin(IVIg) Therapy Product and Services
Table 150. Shuanglin Bio Intravenous Immunoglobulin(IVIg) Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 151. Shuanglin Bio Recent Developments/Updates
Table 152. Shuanglin Bio Competitive Strengths & Weaknesses
Table 153. Boya Bio Basic Information, Manufacturing Base and Competitors
Table 154. Boya Bio Major Business
Table 155. Boya Bio Intravenous Immunoglobulin(IVIg) Therapy Product and Services
Table 156. Boya Bio Intravenous Immunoglobulin(IVIg) Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 157. Boya Bio Recent Developments/Updates
Table 158. Boya Bio Competitive Strengths & Weaknesses
Table 159. Yuanda Shuyang Basic Information, Manufacturing Base and Competitors
Table 160. Yuanda Shuyang Major Business
Table 161. Yuanda Shuyang Intravenous Immunoglobulin(IVIg) Therapy Product and Services
Table 162. Yuanda Shuyang Intravenous Immunoglobulin(IVIg) Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 163. Yuanda Shuyang Recent Developments/Updates
Table 164. Yuanda Shuyang Competitive Strengths & Weaknesses
Table 165. Weiguang Bio Basic Information, Manufacturing Base and Competitors
Table 166. Weiguang Bio Major Business
Table 167. Weiguang Bio Intravenous Immunoglobulin(IVIg) Therapy Product and Services
Table 168. Weiguang Bio Intravenous Immunoglobulin(IVIg) Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 169. Weiguang Bio Recent Developments/Updates
Table 170. Weiguang Bio Competitive Strengths & Weaknesses
Table 171. Nanyue Bio Basic Information, Manufacturing Base and Competitors
Table 172. Nanyue Bio Major Business
Table 173. Nanyue Bio Intravenous Immunoglobulin(IVIg) Therapy Product and Services
Table 174. Nanyue Bio Intravenous Immunoglobulin(IVIg) Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 175. Nanyue Bio Recent Developments/Updates
Table 176. Nanyue Bio Competitive Strengths & Weaknesses
Table 177. KM Biologics Basic Information, Manufacturing Base and Competitors
Table 178. KM Biologics Major Business
Table 179. KM Biologics Intravenous Immunoglobulin(IVIg) Therapy Product and Services
Table 180. KM Biologics Intravenous Immunoglobulin(IVIg) Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 181. KM Biologics Recent Developments/Updates
Table 182. KM Biologics Competitive Strengths & Weaknesses
Table 183. Global Key Players of Intravenous Immunoglobulin(IVIg) Therapy Upstream (Raw Materials)
Table 184. Global Intravenous Immunoglobulin(IVIg) Therapy Typical Customers
Table 185. Intravenous Immunoglobulin(IVIg) Therapy Typical Distributors
Table 1. World Intravenous Immunoglobulin(IVIg) Therapy Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Intravenous Immunoglobulin(IVIg) Therapy Production Value by Region (2021-2026) & (USD Million)
Table 3. World Intravenous Immunoglobulin(IVIg) Therapy Production Value by Region (2027-2032) & (USD Million)
Table 4. World Intravenous Immunoglobulin(IVIg) Therapy Production Value Market Share by Region (2021-2026)
Table 5. World Intravenous Immunoglobulin(IVIg) Therapy Production Value Market Share by Region (2027-2032)
Table 6. World Intravenous Immunoglobulin(IVIg) Therapy Production by Region (2021-2026) & (K Units)
Table 7. World Intravenous Immunoglobulin(IVIg) Therapy Production by Region (2027-2032) & (K Units)
Table 8. World Intravenous Immunoglobulin(IVIg) Therapy Production Market Share by Region (2021-2026)
Table 9. World Intravenous Immunoglobulin(IVIg) Therapy Production Market Share by Region (2027-2032)
Table 10. World Intravenous Immunoglobulin(IVIg) Therapy Average Price by Region (2021-2026) & (US$/Unit)
Table 11. World Intravenous Immunoglobulin(IVIg) Therapy Average Price by Region (2027-2032) & (US$/Unit)
Table 12. Intravenous Immunoglobulin(IVIg) Therapy Major Market Trends
Table 13. World Intravenous Immunoglobulin(IVIg) Therapy Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (K Units)
Table 14. World Intravenous Immunoglobulin(IVIg) Therapy Consumption by Region (2021-2026) & (K Units)
Table 15. World Intravenous Immunoglobulin(IVIg) Therapy Consumption Forecast by Region (2027-2032) & (K Units)
Table 16. World Intravenous Immunoglobulin(IVIg) Therapy Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Intravenous Immunoglobulin(IVIg) Therapy Producers in 2025
Table 18. World Intravenous Immunoglobulin(IVIg) Therapy Production by Manufacturer (2021-2026) & (K Units)
Table 19. Production Market Share of Key Intravenous Immunoglobulin(IVIg) Therapy Producers in 2025
Table 20. World Intravenous Immunoglobulin(IVIg) Therapy Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 21. Global Intravenous Immunoglobulin(IVIg) Therapy Company Evaluation Quadrant
Table 22. World Intravenous Immunoglobulin(IVIg) Therapy Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Intravenous Immunoglobulin(IVIg) Therapy Production Site of Key Manufacturer
Table 24. Intravenous Immunoglobulin(IVIg) Therapy Market: Company Product Type Footprint
Table 25. Intravenous Immunoglobulin(IVIg) Therapy Market: Company Product Application Footprint
Table 26. Intravenous Immunoglobulin(IVIg) Therapy Competitive Factors
Table 27. Intravenous Immunoglobulin(IVIg) Therapy New Entrant and Capacity Expansion Plans
Table 28. Intravenous Immunoglobulin(IVIg) Therapy Mergers & Acquisitions Activity
Table 29. United States VS China Intravenous Immunoglobulin(IVIg) Therapy Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Intravenous Immunoglobulin(IVIg) Therapy Production Comparison, (2021 & 2025 & 2032) & (K Units)
Table 31. United States VS China Intravenous Immunoglobulin(IVIg) Therapy Consumption Comparison, (2021 & 2025 & 2032) & (K Units)
Table 32. United States Based Intravenous Immunoglobulin(IVIg) Therapy Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Intravenous Immunoglobulin(IVIg) Therapy Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Intravenous Immunoglobulin(IVIg) Therapy Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Intravenous Immunoglobulin(IVIg) Therapy Production (2021-2026) & (K Units)
Table 36. United States Based Manufacturers Intravenous Immunoglobulin(IVIg) Therapy Production Market Share (2021-2026)
Table 37. China Based Intravenous Immunoglobulin(IVIg) Therapy Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Intravenous Immunoglobulin(IVIg) Therapy Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Intravenous Immunoglobulin(IVIg) Therapy Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Intravenous Immunoglobulin(IVIg) Therapy Production, (2021-2026) & (K Units)
Table 41. China Based Manufacturers Intravenous Immunoglobulin(IVIg) Therapy Production Market Share (2021-2026)
Table 42. Rest of World Based Intravenous Immunoglobulin(IVIg) Therapy Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Intravenous Immunoglobulin(IVIg) Therapy Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Intravenous Immunoglobulin(IVIg) Therapy Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Intravenous Immunoglobulin(IVIg) Therapy Production, (2021-2026) & (K Units)
Table 46. Rest of World Based Manufacturers Intravenous Immunoglobulin(IVIg) Therapy Production Market Share (2021-2026)
Table 47. World Intravenous Immunoglobulin(IVIg) Therapy Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Intravenous Immunoglobulin(IVIg) Therapy Production by Type (2021-2026) & (K Units)
Table 49. World Intravenous Immunoglobulin(IVIg) Therapy Production by Type (2027-2032) & (K Units)
Table 50. World Intravenous Immunoglobulin(IVIg) Therapy Production Value by Type (2021-2026) & (USD Million)
Table 51. World Intravenous Immunoglobulin(IVIg) Therapy Production Value by Type (2027-2032) & (USD Million)
Table 52. World Intravenous Immunoglobulin(IVIg) Therapy Average Price by Type (2021-2026) & (US$/Unit)
Table 53. World Intravenous Immunoglobulin(IVIg) Therapy Average Price by Type (2027-2032) & (US$/Unit)
Table 54. World Intravenous Immunoglobulin(IVIg) Therapy Production Value by Product Concentration, (USD Million), 2021 & 2025 & 2032
Table 55. World Intravenous Immunoglobulin(IVIg) Therapy Production by Product Concentration (2021-2026) & (K Units)
Table 56. World Intravenous Immunoglobulin(IVIg) Therapy Production by Product Concentration (2027-2032) & (K Units)
Table 57. World Intravenous Immunoglobulin(IVIg) Therapy Production Value by Product Concentration (2021-2026) & (USD Million)
Table 58. World Intravenous Immunoglobulin(IVIg) Therapy Production Value by Product Concentration (2027-2032) & (USD Million)
Table 59. World Intravenous Immunoglobulin(IVIg) Therapy Average Price by Product Concentration (2021-2026) & (US$/Unit)
Table 60. World Intravenous Immunoglobulin(IVIg) Therapy Average Price by Product Concentration (2027-2032) & (US$/Unit)
Table 61. World Intravenous Immunoglobulin(IVIg) Therapy Production Value by Treatment Setting, (USD Million), 2021 & 2025 & 2032
Table 62. World Intravenous Immunoglobulin(IVIg) Therapy Production by Treatment Setting (2021-2026) & (K Units)
Table 63. World Intravenous Immunoglobulin(IVIg) Therapy Production by Treatment Setting (2027-2032) & (K Units)
Table 64. World Intravenous Immunoglobulin(IVIg) Therapy Production Value by Treatment Setting (2021-2026) & (USD Million)
Table 65. World Intravenous Immunoglobulin(IVIg) Therapy Production Value by Treatment Setting (2027-2032) & (USD Million)
Table 66. World Intravenous Immunoglobulin(IVIg) Therapy Average Price by Treatment Setting (2021-2026) & (US$/Unit)
Table 67. World Intravenous Immunoglobulin(IVIg) Therapy Average Price by Treatment Setting (2027-2032) & (US$/Unit)
Table 68. World Intravenous Immunoglobulin(IVIg) Therapy Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 69. World Intravenous Immunoglobulin(IVIg) Therapy Production by Application (2021-2026) & (K Units)
Table 70. World Intravenous Immunoglobulin(IVIg) Therapy Production by Application (2027-2032) & (K Units)
Table 71. World Intravenous Immunoglobulin(IVIg) Therapy Production Value by Application (2021-2026) & (USD Million)
Table 72. World Intravenous Immunoglobulin(IVIg) Therapy Production Value by Application (2027-2032) & (USD Million)
Table 73. World Intravenous Immunoglobulin(IVIg) Therapy Average Price by Application (2021-2026) & (US$/Unit)
Table 74. World Intravenous Immunoglobulin(IVIg) Therapy Average Price by Application (2027-2032) & (US$/Unit)
Table 75. Takeda Basic Information, Manufacturing Base and Competitors
Table 76. Takeda Major Business
Table 77. Takeda Intravenous Immunoglobulin(IVIg) Therapy Product and Services
Table 78. Takeda Intravenous Immunoglobulin(IVIg) Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. Takeda Recent Developments/Updates
Table 80. Takeda Competitive Strengths & Weaknesses
Table 81. CSL Basic Information, Manufacturing Base and Competitors
Table 82. CSL Major Business
Table 83. CSL Intravenous Immunoglobulin(IVIg) Therapy Product and Services
Table 84. CSL Intravenous Immunoglobulin(IVIg) Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. CSL Recent Developments/Updates
Table 86. CSL Competitive Strengths & Weaknesses
Table 87. Grifols Basic Information, Manufacturing Base and Competitors
Table 88. Grifols Major Business
Table 89. Grifols Intravenous Immunoglobulin(IVIg) Therapy Product and Services
Table 90. Grifols Intravenous Immunoglobulin(IVIg) Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 91. Grifols Recent Developments/Updates
Table 92. Grifols Competitive Strengths & Weaknesses
Table 93. Octapharma Basic Information, Manufacturing Base and Competitors
Table 94. Octapharma Major Business
Table 95. Octapharma Intravenous Immunoglobulin(IVIg) Therapy Product and Services
Table 96. Octapharma Intravenous Immunoglobulin(IVIg) Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 97. Octapharma Recent Developments/Updates
Table 98. Octapharma Competitive Strengths & Weaknesses
Table 99. Kedrion Basic Information, Manufacturing Base and Competitors
Table 100. Kedrion Major Business
Table 101. Kedrion Intravenous Immunoglobulin(IVIg) Therapy Product and Services
Table 102. Kedrion Intravenous Immunoglobulin(IVIg) Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 103. Kedrion Recent Developments/Updates
Table 104. Kedrion Competitive Strengths & Weaknesses
Table 105. LFB Group Basic Information, Manufacturing Base and Competitors
Table 106. LFB Group Major Business
Table 107. LFB Group Intravenous Immunoglobulin(IVIg) Therapy Product and Services
Table 108. LFB Group Intravenous Immunoglobulin(IVIg) Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 109. LFB Group Recent Developments/Updates
Table 110. LFB Group Competitive Strengths & Weaknesses
Table 111. Biotest Basic Information, Manufacturing Base and Competitors
Table 112. Biotest Major Business
Table 113. Biotest Intravenous Immunoglobulin(IVIg) Therapy Product and Services
Table 114. Biotest Intravenous Immunoglobulin(IVIg) Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 115. Biotest Recent Developments/Updates
Table 116. Biotest Competitive Strengths & Weaknesses
Table 117. BPL Basic Information, Manufacturing Base and Competitors
Table 118. BPL Major Business
Table 119. BPL Intravenous Immunoglobulin(IVIg) Therapy Product and Services
Table 120. BPL Intravenous Immunoglobulin(IVIg) Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 121. BPL Recent Developments/Updates
Table 122. BPL Competitive Strengths & Weaknesses
Table 123. RAAS Basic Information, Manufacturing Base and Competitors
Table 124. RAAS Major Business
Table 125. RAAS Intravenous Immunoglobulin(IVIg) Therapy Product and Services
Table 126. RAAS Intravenous Immunoglobulin(IVIg) Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 127. RAAS Recent Developments/Updates
Table 128. RAAS Competitive Strengths & Weaknesses
Table 129. CBPO Basic Information, Manufacturing Base and Competitors
Table 130. CBPO Major Business
Table 131. CBPO Intravenous Immunoglobulin(IVIg) Therapy Product and Services
Table 132. CBPO Intravenous Immunoglobulin(IVIg) Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 133. CBPO Recent Developments/Updates
Table 134. CBPO Competitive Strengths & Weaknesses
Table 135. Hualan Bio Basic Information, Manufacturing Base and Competitors
Table 136. Hualan Bio Major Business
Table 137. Hualan Bio Intravenous Immunoglobulin(IVIg) Therapy Product and Services
Table 138. Hualan Bio Intravenous Immunoglobulin(IVIg) Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 139. Hualan Bio Recent Developments/Updates
Table 140. Hualan Bio Competitive Strengths & Weaknesses
Table 141. Tiantan Bio Basic Information, Manufacturing Base and Competitors
Table 142. Tiantan Bio Major Business
Table 143. Tiantan Bio Intravenous Immunoglobulin(IVIg) Therapy Product and Services
Table 144. Tiantan Bio Intravenous Immunoglobulin(IVIg) Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 145. Tiantan Bio Recent Developments/Updates
Table 146. Tiantan Bio Competitive Strengths & Weaknesses
Table 147. Shuanglin Bio Basic Information, Manufacturing Base and Competitors
Table 148. Shuanglin Bio Major Business
Table 149. Shuanglin Bio Intravenous Immunoglobulin(IVIg) Therapy Product and Services
Table 150. Shuanglin Bio Intravenous Immunoglobulin(IVIg) Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 151. Shuanglin Bio Recent Developments/Updates
Table 152. Shuanglin Bio Competitive Strengths & Weaknesses
Table 153. Boya Bio Basic Information, Manufacturing Base and Competitors
Table 154. Boya Bio Major Business
Table 155. Boya Bio Intravenous Immunoglobulin(IVIg) Therapy Product and Services
Table 156. Boya Bio Intravenous Immunoglobulin(IVIg) Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 157. Boya Bio Recent Developments/Updates
Table 158. Boya Bio Competitive Strengths & Weaknesses
Table 159. Yuanda Shuyang Basic Information, Manufacturing Base and Competitors
Table 160. Yuanda Shuyang Major Business
Table 161. Yuanda Shuyang Intravenous Immunoglobulin(IVIg) Therapy Product and Services
Table 162. Yuanda Shuyang Intravenous Immunoglobulin(IVIg) Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 163. Yuanda Shuyang Recent Developments/Updates
Table 164. Yuanda Shuyang Competitive Strengths & Weaknesses
Table 165. Weiguang Bio Basic Information, Manufacturing Base and Competitors
Table 166. Weiguang Bio Major Business
Table 167. Weiguang Bio Intravenous Immunoglobulin(IVIg) Therapy Product and Services
Table 168. Weiguang Bio Intravenous Immunoglobulin(IVIg) Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 169. Weiguang Bio Recent Developments/Updates
Table 170. Weiguang Bio Competitive Strengths & Weaknesses
Table 171. Nanyue Bio Basic Information, Manufacturing Base and Competitors
Table 172. Nanyue Bio Major Business
Table 173. Nanyue Bio Intravenous Immunoglobulin(IVIg) Therapy Product and Services
Table 174. Nanyue Bio Intravenous Immunoglobulin(IVIg) Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 175. Nanyue Bio Recent Developments/Updates
Table 176. Nanyue Bio Competitive Strengths & Weaknesses
Table 177. KM Biologics Basic Information, Manufacturing Base and Competitors
Table 178. KM Biologics Major Business
Table 179. KM Biologics Intravenous Immunoglobulin(IVIg) Therapy Product and Services
Table 180. KM Biologics Intravenous Immunoglobulin(IVIg) Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 181. KM Biologics Recent Developments/Updates
Table 182. KM Biologics Competitive Strengths & Weaknesses
Table 183. Global Key Players of Intravenous Immunoglobulin(IVIg) Therapy Upstream (Raw Materials)
Table 184. Global Intravenous Immunoglobulin(IVIg) Therapy Typical Customers
Table 185. Intravenous Immunoglobulin(IVIg) Therapy Typical Distributors
LIST OF FIGURES
Figure 1. Intravenous Immunoglobulin(IVIg) Therapy Picture
Figure 2. World Intravenous Immunoglobulin(IVIg) Therapy Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Intravenous Immunoglobulin(IVIg) Therapy Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Intravenous Immunoglobulin(IVIg) Therapy Production (2021-2032) & (K Units)
Figure 5. World Intravenous Immunoglobulin(IVIg) Therapy Average Price (2021-2032) & (US$/Unit)
Figure 6. World Intravenous Immunoglobulin(IVIg) Therapy Production Value Market Share by Region (2021-2032)
Figure 7. World Intravenous Immunoglobulin(IVIg) Therapy Production Market Share by Region (2021-2032)
Figure 8. North America Intravenous Immunoglobulin(IVIg) Therapy Production (2021-2032) & (K Units)
Figure 9. Europe Intravenous Immunoglobulin(IVIg) Therapy Production (2021-2032) & (K Units)
Figure 10. China Intravenous Immunoglobulin(IVIg) Therapy Production (2021-2032) & (K Units)
Figure 11. Japan Intravenous Immunoglobulin(IVIg) Therapy Production (2021-2032) & (K Units)
Figure 12. Intravenous Immunoglobulin(IVIg) Therapy Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Intravenous Immunoglobulin(IVIg) Therapy Consumption (2021-2032) & (K Units)
Figure 15. World Intravenous Immunoglobulin(IVIg) Therapy Consumption Market Share by Region (2021-2032)
Figure 16. United States Intravenous Immunoglobulin(IVIg) Therapy Consumption (2021-2032) & (K Units)
Figure 17. China Intravenous Immunoglobulin(IVIg) Therapy Consumption (2021-2032) & (K Units)
Figure 18. Europe Intravenous Immunoglobulin(IVIg) Therapy Consumption (2021-2032) & (K Units)
Figure 19. Japan Intravenous Immunoglobulin(IVIg) Therapy Consumption (2021-2032) & (K Units)
Figure 20. South Korea Intravenous Immunoglobulin(IVIg) Therapy Consumption (2021-2032) & (K Units)
Figure 21. ASEAN Intravenous Immunoglobulin(IVIg) Therapy Consumption (2021-2032) & (K Units)
Figure 22. India Intravenous Immunoglobulin(IVIg) Therapy Consumption (2021-2032) & (K Units)
Figure 23. Producer Shipments of Intravenous Immunoglobulin(IVIg) Therapy by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 24. Global Four-firm Concentration Ratios (CR4) for Intravenous Immunoglobulin(IVIg) Therapy Markets in 2025
Figure 25. Global Four-firm Concentration Ratios (CR8) for Intravenous Immunoglobulin(IVIg) Therapy Markets in 2025
Figure 26. United States VS China: Intravenous Immunoglobulin(IVIg) Therapy Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 27. United States VS China: Intravenous Immunoglobulin(IVIg) Therapy Production Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Intravenous Immunoglobulin(IVIg) Therapy Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States Based Manufacturers Intravenous Immunoglobulin(IVIg) Therapy Production Market Share 2025
Figure 30. China Based Manufacturers Intravenous Immunoglobulin(IVIg) Therapy Production Market Share 2025
Figure 31. Rest of World Based Manufacturers Intravenous Immunoglobulin(IVIg) Therapy Production Market Share 2025
Figure 32. World Intravenous Immunoglobulin(IVIg) Therapy Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 33. World Intravenous Immunoglobulin(IVIg) Therapy Production Value Market Share by Type in 2025
Figure 34. Liquid
Figure 35. Powder
Figure 36. World Intravenous Immunoglobulin(IVIg) Therapy Production Market Share by Type (2021-2032)
Figure 37. World Intravenous Immunoglobulin(IVIg) Therapy Production Value Market Share by Type (2021-2032)
Figure 38. World Intravenous Immunoglobulin(IVIg) Therapy Average Price by Type (2021-2032) & (US$/Unit)
Figure 39. World Intravenous Immunoglobulin(IVIg) Therapy Production Value by Product Concentration, (USD Million), 2021 & 2025 & 2032
Figure 40. World Intravenous Immunoglobulin(IVIg) Therapy Production Value Market Share by Product Concentration in 2025
Figure 41. Low Concentration
Figure 42. Medium Concentration
Figure 43. High Concentration
Figure 44. World Intravenous Immunoglobulin(IVIg) Therapy Production Market Share by Product Concentration (2021-2032)
Figure 45. World Intravenous Immunoglobulin(IVIg) Therapy Production Value Market Share by Product Concentration (2021-2032)
Figure 46. World Intravenous Immunoglobulin(IVIg) Therapy Average Price by Product Concentration (2021-2032) & (US$/Unit)
Figure 47. World Intravenous Immunoglobulin(IVIg) Therapy Production Value by Treatment Setting, (USD Million), 2021 & 2025 & 2032
Figure 48. World Intravenous Immunoglobulin(IVIg) Therapy Production Value Market Share by Treatment Setting in 2025
Figure 49. Acute Therapy
Figure 50. Maintenance Therapy
Figure 51. Critical Care
Figure 52. World Intravenous Immunoglobulin(IVIg) Therapy Production Market Share by Treatment Setting (2021-2032)
Figure 53. World Intravenous Immunoglobulin(IVIg) Therapy Production Value Market Share by Treatment Setting (2021-2032)
Figure 54. World Intravenous Immunoglobulin(IVIg) Therapy Average Price by Treatment Setting (2021-2032) & (US$/Unit)
Figure 55. World Intravenous Immunoglobulin(IVIg) Therapy Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 56. World Intravenous Immunoglobulin(IVIg) Therapy Production Value Market Share by Application in 2025
Figure 57. Immunodeficiency
Figure 58. Autoimmune Disease
Figure 59. Acute Infection
Figure 60. Others
Figure 61. World Intravenous Immunoglobulin(IVIg) Therapy Production Market Share by Application (2021-2032)
Figure 62. World Intravenous Immunoglobulin(IVIg) Therapy Production Value Market Share by Application (2021-2032)
Figure 63. World Intravenous Immunoglobulin(IVIg) Therapy Average Price by Application (2021-2032) & (US$/Unit)
Figure 64. Intravenous Immunoglobulin(IVIg) Therapy Industry Chain
Figure 65. Intravenous Immunoglobulin(IVIg) Therapy Procurement Model
Figure 66. Intravenous Immunoglobulin(IVIg) Therapy Sales Model
Figure 67. Intravenous Immunoglobulin(IVIg) Therapy Sales Channels, Direct Sales, and Distribution
Figure 68. Methodology
Figure 69. Research Process and Data Source
Figure 1. Intravenous Immunoglobulin(IVIg) Therapy Picture
Figure 2. World Intravenous Immunoglobulin(IVIg) Therapy Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Intravenous Immunoglobulin(IVIg) Therapy Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Intravenous Immunoglobulin(IVIg) Therapy Production (2021-2032) & (K Units)
Figure 5. World Intravenous Immunoglobulin(IVIg) Therapy Average Price (2021-2032) & (US$/Unit)
Figure 6. World Intravenous Immunoglobulin(IVIg) Therapy Production Value Market Share by Region (2021-2032)
Figure 7. World Intravenous Immunoglobulin(IVIg) Therapy Production Market Share by Region (2021-2032)
Figure 8. North America Intravenous Immunoglobulin(IVIg) Therapy Production (2021-2032) & (K Units)
Figure 9. Europe Intravenous Immunoglobulin(IVIg) Therapy Production (2021-2032) & (K Units)
Figure 10. China Intravenous Immunoglobulin(IVIg) Therapy Production (2021-2032) & (K Units)
Figure 11. Japan Intravenous Immunoglobulin(IVIg) Therapy Production (2021-2032) & (K Units)
Figure 12. Intravenous Immunoglobulin(IVIg) Therapy Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Intravenous Immunoglobulin(IVIg) Therapy Consumption (2021-2032) & (K Units)
Figure 15. World Intravenous Immunoglobulin(IVIg) Therapy Consumption Market Share by Region (2021-2032)
Figure 16. United States Intravenous Immunoglobulin(IVIg) Therapy Consumption (2021-2032) & (K Units)
Figure 17. China Intravenous Immunoglobulin(IVIg) Therapy Consumption (2021-2032) & (K Units)
Figure 18. Europe Intravenous Immunoglobulin(IVIg) Therapy Consumption (2021-2032) & (K Units)
Figure 19. Japan Intravenous Immunoglobulin(IVIg) Therapy Consumption (2021-2032) & (K Units)
Figure 20. South Korea Intravenous Immunoglobulin(IVIg) Therapy Consumption (2021-2032) & (K Units)
Figure 21. ASEAN Intravenous Immunoglobulin(IVIg) Therapy Consumption (2021-2032) & (K Units)
Figure 22. India Intravenous Immunoglobulin(IVIg) Therapy Consumption (2021-2032) & (K Units)
Figure 23. Producer Shipments of Intravenous Immunoglobulin(IVIg) Therapy by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 24. Global Four-firm Concentration Ratios (CR4) for Intravenous Immunoglobulin(IVIg) Therapy Markets in 2025
Figure 25. Global Four-firm Concentration Ratios (CR8) for Intravenous Immunoglobulin(IVIg) Therapy Markets in 2025
Figure 26. United States VS China: Intravenous Immunoglobulin(IVIg) Therapy Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 27. United States VS China: Intravenous Immunoglobulin(IVIg) Therapy Production Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Intravenous Immunoglobulin(IVIg) Therapy Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States Based Manufacturers Intravenous Immunoglobulin(IVIg) Therapy Production Market Share 2025
Figure 30. China Based Manufacturers Intravenous Immunoglobulin(IVIg) Therapy Production Market Share 2025
Figure 31. Rest of World Based Manufacturers Intravenous Immunoglobulin(IVIg) Therapy Production Market Share 2025
Figure 32. World Intravenous Immunoglobulin(IVIg) Therapy Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 33. World Intravenous Immunoglobulin(IVIg) Therapy Production Value Market Share by Type in 2025
Figure 34. Liquid
Figure 35. Powder
Figure 36. World Intravenous Immunoglobulin(IVIg) Therapy Production Market Share by Type (2021-2032)
Figure 37. World Intravenous Immunoglobulin(IVIg) Therapy Production Value Market Share by Type (2021-2032)
Figure 38. World Intravenous Immunoglobulin(IVIg) Therapy Average Price by Type (2021-2032) & (US$/Unit)
Figure 39. World Intravenous Immunoglobulin(IVIg) Therapy Production Value by Product Concentration, (USD Million), 2021 & 2025 & 2032
Figure 40. World Intravenous Immunoglobulin(IVIg) Therapy Production Value Market Share by Product Concentration in 2025
Figure 41. Low Concentration
Figure 42. Medium Concentration
Figure 43. High Concentration
Figure 44. World Intravenous Immunoglobulin(IVIg) Therapy Production Market Share by Product Concentration (2021-2032)
Figure 45. World Intravenous Immunoglobulin(IVIg) Therapy Production Value Market Share by Product Concentration (2021-2032)
Figure 46. World Intravenous Immunoglobulin(IVIg) Therapy Average Price by Product Concentration (2021-2032) & (US$/Unit)
Figure 47. World Intravenous Immunoglobulin(IVIg) Therapy Production Value by Treatment Setting, (USD Million), 2021 & 2025 & 2032
Figure 48. World Intravenous Immunoglobulin(IVIg) Therapy Production Value Market Share by Treatment Setting in 2025
Figure 49. Acute Therapy
Figure 50. Maintenance Therapy
Figure 51. Critical Care
Figure 52. World Intravenous Immunoglobulin(IVIg) Therapy Production Market Share by Treatment Setting (2021-2032)
Figure 53. World Intravenous Immunoglobulin(IVIg) Therapy Production Value Market Share by Treatment Setting (2021-2032)
Figure 54. World Intravenous Immunoglobulin(IVIg) Therapy Average Price by Treatment Setting (2021-2032) & (US$/Unit)
Figure 55. World Intravenous Immunoglobulin(IVIg) Therapy Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 56. World Intravenous Immunoglobulin(IVIg) Therapy Production Value Market Share by Application in 2025
Figure 57. Immunodeficiency
Figure 58. Autoimmune Disease
Figure 59. Acute Infection
Figure 60. Others
Figure 61. World Intravenous Immunoglobulin(IVIg) Therapy Production Market Share by Application (2021-2032)
Figure 62. World Intravenous Immunoglobulin(IVIg) Therapy Production Value Market Share by Application (2021-2032)
Figure 63. World Intravenous Immunoglobulin(IVIg) Therapy Average Price by Application (2021-2032) & (US$/Unit)
Figure 64. Intravenous Immunoglobulin(IVIg) Therapy Industry Chain
Figure 65. Intravenous Immunoglobulin(IVIg) Therapy Procurement Model
Figure 66. Intravenous Immunoglobulin(IVIg) Therapy Sales Model
Figure 67. Intravenous Immunoglobulin(IVIg) Therapy Sales Channels, Direct Sales, and Distribution
Figure 68. Methodology
Figure 69. Research Process and Data Source
